EcoR1 Capital, LLC Insider Trading $ANAB ANAPTYSBIO, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EcoR1 Capital, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EcoR1 Capital, LLC. EcoR1 Capital, LLC is 10% Owner in GENVEC INC ($GNVC) and 10% Owner in ANAPTYSBIO, INC ($ANAB) and Director in ANAPTYSBIO, INC ($ANAB) and 10% Owner in PROTHENA CORP PUBLIC LTD CO ($PRTA) and 10% Owner in Surface Oncology, Inc. ($SURF).
EcoR1 Capital, LLC in ANAPTYSBIO, INC
Trading Symbol: ANABIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EcoR1 Capital, LLC: Director, 10% Owner
Holdings: 7,334,624 shares
Current Value: $135,983,929
Latest Transaction: May 04 2021
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of EcoR1 Capital, LLC in ANAPTYSBIO, INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAB, GNVC, PRTA, SURF
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.25 | 165,000 | 3,835,755 | 7,520,424 | 7.4 M to 7.5 M (+2.24 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.31 | 20,800 | 484,873 | 7,355,424 | 7.3 M to 7.4 M (+0.28 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.16 | 35,700 | 826,816 | 7,334,624 | 7.3 M to 7.3 M (+0.49 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.25 | 165,000 | 3,835,755 | 7,520,424 | 7.4 M to 7.5 M (+2.24 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.31 | 20,800 | 484,873 | 7,355,424 | 7.3 M to 7.4 M (+0.28 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.16 | 35,700 | 826,816 | 7,334,624 | 7.3 M to 7.3 M (+0.49 %) |
Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.82 | 33,800 | 805,089 | 7,298,924 | 7.3 M to 7.3 M (+0.47 %) |
Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.80 | 13,900 | 330,859 | 7,265,124 | 7.3 M to 7.3 M (+0.19 %) |
Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.54 | 99,600 | 2,344,285 | 7,251,224 | 7.2 M to 7.3 M (+1.39 %) |
Mar 10 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | 10% Owner | Buy | P | 18.70 | 531,000 | 9,928,426 | 7,151,624 | 6.6 M to 7.2 M (+8.02 %) |
Mar 10 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | 10% Owner | Buy | P | 18.97 | 2,777,800 | 52,694,310 | 6,620,624 | 3.8 M to 6.6 M (+72.29 %) |
Page: 1